A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HNP1 / human neutrophil peptide 1

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HNP1  (>> Co-occurring Abbreviation)
Long Form:   human neutrophil peptide 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Adenovirus-α-Defensin Complexes Induce NLRP3-Associated Maturation of Human Phagocytes via Toll-Like Receptor 4 Engagement. AMPs, HAdV, IL-1beta, TLR4
2021 Aptamer selection against alpha-defensin human neutrophil peptide 1 on an integrated microfluidic system for diagnosis of periprosthetic joint infections. ELISA, PJIs, SELEX, SF
2021 Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates. pHNP1
2020 Cooperative Function of LL-37 and HNP1 Protects Mammalian Cell Membranes from Lysis. ---
2020 ExPortal and the LiaFSR Regulatory System Coordinate the Response to Cell Membrane Stress in Streptococcus pyogenes. GAS
2020 Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection. FN, SSSI
2018 Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases. ---
2018 Neutralization of Pseudomonas auruginosa Exotoxin A by human neutrophil peptide 1. ETA
2018 Secretion expression of human neutrophil peptide 1 (HNP1) in Pichia pastoris and its functional analysis against antibiotic-resistant Helicobacter pylori. EGFP, FHNP1, H. pylori, P. Pichia
10  2018 Silk-Based Antimicrobial Polymers as a New Platform to Design Drug-Free Materials to Impede Microbial Infections. HEP, SF, SSI
11  2017 Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice. L. major
12  2017 Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance. ---
13  2016 Alarmin human alpha defensin HNP1 activates plasmacytoid dendritic cells by triggering NF-kappaB and IRF1 signaling pathways. IRF-1, pDCs
14  2016 Neutrophil-derived alpha defensins control inflammation by inhibiting macrophage mRNA translation. ---
15  2016 Structure-Based Design of Peptidic Inhibitors of the Interaction between CC Chemokine Ligand 5 (CCL5) and Human Neutrophil Peptides 1 (HNP1). CCL5, PPIs
16  2015 Identification of innate immune antiretroviral factors during invivo and invitro exposure to HIV-1. hBD, HC, HESN, SP
17  2015 The extracytoplasmic linker peptide of the sensor protein SaeS tunes the kinase activity required for staphylococcal virulence in response to host signals. TCSs
18  2015 The GraS Sensor in Staphylococcus aureus Mediates Resistance to Host Defense Peptides Differing in Mechanisms of Action. ANX, CDP, EL, ENR, hBD-2, HDPs, PRM
19  2014 Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. AdV, HD5, HPV
20  2013 Emergence of daptomycin resistance in daptomycin-naive rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms. CM, DAP-R, DAP-S, L-PG, MRSA, PG, SNPs, tPMPs
21  2013 Role of the LytSR two-component regulatory system in adaptation to cationic antimicrobial peptides in Staphylococcus aureus. CAP, CCCP, CM, DAP, HDPs, TCRS, tPMPs
22  2012 Lipid composition is a determinant for human defensin HNP1 selectivity. ---
23  2011 Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. tPMPs, VRE
24  2011 In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. CAP, DAP, HDPs, MRSA, PMB, tPMPs
25  2010 Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. HDPs, MRSA, RB, tPMPs
26  2010 Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. ---
27  2008 Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. BKV, HD5
28  2007 Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): inactivation of virus particles and induction of a type I interferon-related response. AMP, IFN, ISGs, VHSV
29  2007 Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. tPMP-1
30  2007 In vivo modulation of the rainbow trout (Oncorhynchus mykiss) immune response by the human alpha defensin 1, HNP1. AMPs, IFN, VHSV
31  2006 Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family. DT
32  2006 The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. OSCC
33  2005 Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. APs, CM, CW, MP, tPMP-1
34  2005 Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form. aAFs, Cal-C, ELISA, GA, IAI, PPROM, SELDI-TOF
35  2004 Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. DEFT, HIV-1, RTDs
36  2003 Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes. PMN, TNF-alpha
37  2003 An improved growth hormone reporter gene shows a different pattern of transactivation by promoter fragments. hGH
38  2000 Large-scale synthesis and functional elements for the antimicrobial activity of defensins. ---